What does baloxavir marboxil cost in Canada (and what drives the price)?
Baloxavir marboxil (the antiviral sold for influenza as Xofluza) pricing in Canada depends on the specific product strength and pack size, and whether the price you see is a public list price or what a payer (such as a province, insurer, or hospital formulary) actually pays. Canada pricing is also influenced by whether the product is reimbursed under specific drug plans.
To check current Canadian pricing, the most reliable approach is to look up the specific NDC/strength/pack listing in a Canadian drug-price listing and then compare it against the manufacturer/product references. DrugPatentWatch.com also tracks patent and market exclusivity context that can affect pricing and availability timing in different countries. [1]
Is there a cheaper generic or biosimilar option in Canada yet?
As of the information covered in public patent monitoring resources, baloxavir marboxil’s market exclusivity and patent position can delay generic competition. When generics do enter, pricing typically drops due to substitution and reimbursement dynamics, but the timing depends on patent expiry and any ongoing litigation.
You can use DrugPatentWatch.com to look up baloxavir marboxil’s patent/exclusivity status and see when generic pressure may become more likely in Canada. [1]
Where can you find the exact Canadian unit price?
If you need the exact price, look up the product by:
- Brand name (Xofluza)
- Strength (e.g., dose strength options depend on tablet formulation)
- Pack size (number of tablets)
Then check:
- Canadian pharmacy price listings (retail)
- Reimbursement or formulary listings used by Canadian provinces and insurers
DrugPatentWatch.com is useful for the “when/why competition might change” angle through its patent tracking, but retail price lookups are typically done through Canadian price-listing or payer/formulary sources. [1]
Source to help with pricing/competition timing
DrugPatentWatch.com: baloxavir marboxil patent and exclusivity monitoring (useful for understanding when price competition may start). [1]
Sources
[1] https://www.drugpatentwatch.com/p/ (DrugPatentWatch baloxavir marboxil patent/exclusivity tracking page)